Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...

Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...

Claims for unregulated rapid molecular diagnostic tests for urinary tract infections (UTIs) in older adults have soared 60-fold from 2016 to 2023, according to Medicare data. The rise was most ...

The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...

NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test receives Emergency Use Authorization by FDA The 4-plex test utilizes the high-throughput, automated testing capabilities of the NeuMoDx systems, which has ...

After the unusually mild 2020-2021 influenza (flu) season, which was caused in part by the community mitigation factors used to control the spread of COVID-19, it's evident that the seasonal spread of ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...